Cargando…

A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients

BACKGROUND: A palliative approach at the end of life typically involves forgoing certain drugs and procedures and starting others - weighing burden against potential benefit. An assessment of the palliative approach may be undertaken by investigating which drugs and procedures are used in the dying...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Emily, Costantini, Massimo, Pasman, H Roeline, Onwuteaka-Philipsen, Bregje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219049/
https://www.ncbi.nlm.nih.gov/pubmed/25410710
http://dx.doi.org/10.1186/s12913-014-0496-2
_version_ 1782342525895311360
author West, Emily
Costantini, Massimo
Pasman, H Roeline
Onwuteaka-Philipsen, Bregje
author_facet West, Emily
Costantini, Massimo
Pasman, H Roeline
Onwuteaka-Philipsen, Bregje
author_sort West, Emily
collection PubMed
description BACKGROUND: A palliative approach at the end of life typically involves forgoing certain drugs and procedures and starting others - weighing burden against potential benefit. An assessment of the palliative approach may be undertaken by investigating which drugs and procedures are used in the dying phase, and at what frequencies. METHODS: Drugs were classified as potentially (in)appropriate based on expert classification. Procedures were classed as therapeutic or diagnostic. 271 consecutive cancer deaths from across 16 hospital general wards and 5 hospices in Italy gathered data on drugs and procedures in the final three days of life through a standardised form. Differences between the two groups were tested using chi-square testing, and logistic regressions were performed to control for patient characteristics. RESULTS: 75.0% of patients in hospital received 3 or more potentially inappropriate drugs in their last three days of life, against 42.6% in hospice. Diagnostic procedures were carried out more frequently in hospital. Multivariate logistic regression showed that when data was controlled for patient characteristics, setting had a unique contribution to the differences found in use of drugs and procedures. CONCLUSION: The data indicates a need for improvement in the hospital setting concerning recognising the need for palliative care, and ensuring a timely introduction of this approach.
format Online
Article
Text
id pubmed-4219049
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42190492014-11-05 A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients West, Emily Costantini, Massimo Pasman, H Roeline Onwuteaka-Philipsen, Bregje BMC Health Serv Res Research Article BACKGROUND: A palliative approach at the end of life typically involves forgoing certain drugs and procedures and starting others - weighing burden against potential benefit. An assessment of the palliative approach may be undertaken by investigating which drugs and procedures are used in the dying phase, and at what frequencies. METHODS: Drugs were classified as potentially (in)appropriate based on expert classification. Procedures were classed as therapeutic or diagnostic. 271 consecutive cancer deaths from across 16 hospital general wards and 5 hospices in Italy gathered data on drugs and procedures in the final three days of life through a standardised form. Differences between the two groups were tested using chi-square testing, and logistic regressions were performed to control for patient characteristics. RESULTS: 75.0% of patients in hospital received 3 or more potentially inappropriate drugs in their last three days of life, against 42.6% in hospice. Diagnostic procedures were carried out more frequently in hospital. Multivariate logistic regression showed that when data was controlled for patient characteristics, setting had a unique contribution to the differences found in use of drugs and procedures. CONCLUSION: The data indicates a need for improvement in the hospital setting concerning recognising the need for palliative care, and ensuring a timely introduction of this approach. BioMed Central 2014-10-25 /pmc/articles/PMC4219049/ /pubmed/25410710 http://dx.doi.org/10.1186/s12913-014-0496-2 Text en © West et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
West, Emily
Costantini, Massimo
Pasman, H Roeline
Onwuteaka-Philipsen, Bregje
A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title_full A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title_fullStr A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title_full_unstemmed A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title_short A comparison of drugs and procedures of care in the Italian hospice and hospital settings: the final three days of life for cancer patients
title_sort comparison of drugs and procedures of care in the italian hospice and hospital settings: the final three days of life for cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219049/
https://www.ncbi.nlm.nih.gov/pubmed/25410710
http://dx.doi.org/10.1186/s12913-014-0496-2
work_keys_str_mv AT westemily acomparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT costantinimassimo acomparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT pasmanhroeline acomparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT onwuteakaphilipsenbregje acomparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT acomparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT westemily comparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT costantinimassimo comparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT pasmanhroeline comparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT onwuteakaphilipsenbregje comparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients
AT comparisonofdrugsandproceduresofcareintheitalianhospiceandhospitalsettingsthefinalthreedaysoflifeforcancerpatients